The Association of Genetic Markers for Type 2 Diabetes with Prediabetic Status - Cross-Sectional Data of a Diabetes Prevention Trial

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zyriax, Birgit Christiane ^a   Salazar, Ramona ^b   Hoeppner, Wolfgang ^b   Vettorazzi, Eik ^a   Herder, Christian ^c   Windler, Eberhard ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Bioglobe GmbH   (Germany)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; LEPTIN;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXPLORATORY RESEARCH; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GERMANY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

AGE FACTORS; ALLELES; ANTHROPOMETRY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; GERMANY; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDIABETIC STATE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84884749803     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075807     Document Type: Article

References (79)

1. King H, Aubert RE, Herman WH, (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431.
2. Lam DW, LeRoith D, (2012) The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes 19: 93-96.
3. Hu FB, (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34: 1249-1257.
4. International Diabetes Federation (2011) IDF Diabetes Atlas, 5th edition. Bruessels, Belgium.
5. Coutinho M, Gerstein HC, Wang YS, (1999) The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240.
6. Port SC, Goodarzi MO, Boyle NG, Jennrich RI, (2005) Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J 150: 209-214.
7. Qiao Q, Jousilahti P, Eriksson J, (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26: 2910-2914.
8. Zyriax BC, Boeing H, Windler E, (2005) Nutrition is a powerful independent risk factor for coronary heart disease in women- The CORA study: a population-based case-control study. Eur J Clin Nutr 59: 1201-1207.
9. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, et al. (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116: 151-157.
10. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33Suppl 1: S62-S69.
11. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M, (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379: 2279-2290.
12. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, et al. (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285: 2109-2113.
13. Diabetes Prevention Program (DPP) Research Group (2002) The Diabetes Prevention Program (DPP) description of lifestyle intervention. Diabetes Care 25: 2165-2171.
14. Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, et al. (2008) Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care 31: 857-862.
15. Li S, Shin HJ, Ding EL, van Dam RM, (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302: 179-188.
16. Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, et al. (2006) Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 29: 1501-1505.
17. Zhang Z, Lanza E, Ross AC, Albert PS, Colburn NH, et al. (2011) A high-legume low-glycemic index diet reduces fasting plasma leptin in middle-aged insulin-resistant and-sensitive men. Eur J Clin Nutr 65: 415-418.
18. Cardellini M, Andreozzi F, Laratta E, Marini MA, Lauro R, et al. (2007) Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev 23: 141-155.
19. Zyriax BC, Algenstaedt P, Hess UF, Schöffauer M, Bamberger C, et al. (2008) Factors contributing to the risk of cardiovascular disease reflected by plasma adiponectin: data from the coronary risk factors for atherosclerosis in women (CORA) study. Atherosclerosis. 200: 403-409.
20. Thorand B, Zierer A, Baumert J, Meisinger C, Herder C, et al. (2010) Associations between leptin and the leptin/adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA/KORA Augsburg study 1984-2002. Diabet Med 27: 1004-1011.
21. Ortega-Azorín C, Sorlí JV, Asensio EM, Coltell O, Martínez-González MA, et al. (2012) Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol 11: 137.
22. InterAct Consortium, (2013) The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 56: 60-69.
23. Herder C, Roden M, (2011) Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur J Clin Invest 41: 679-692.
24. Linder K, Wagner R, Hatziagelaki E, Ketterer C, Heni M, et al. (2012) Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals. PLoS One 7: e38224. Available: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.0000045. Accessed 27 August 2013.
25. McCarthy MI, (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363: 2339-2350.
26. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet 42: 579-589.
27. Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, et al. (2010) Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 19: 2706-2715.
28. Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, et al. (2010) A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 42: 864-868.
29. Culverhouse R, Suarez BK, Lin J, Reich T, (2002) A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet 70: 416-471.
30. Moore JH, Williams SM, (2005) Traversing the conceptual divided between biological and statistical epistasis: systems biology and a more modern synthesis. BioEssays 27: 637-646.
31. Heidema AG, Boer JM, Nagelkerke N, Mariman EC, van der A DL, et al. (2006) The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases. BMC Genet 7: 23. Available: http://www.biomedcentral.com/1471-2156/7/23. Accessed 27 August 2013.
32. Lunetta KL, Hayward LB, Segal J, Van Eerdewegh P (2004) Screening large-scale association study data: exploiting interactions using random forests. BMC Genet 5: 32. Available: http://www.biomedcentral.com/1471-2156/5/32. Accessed 27 August 2013.
33. Bureau A, Dupuis J, Falls K, Lunetta KL, Hayward B, et al. (2005) Identifying SNPs predictive of phenotype using random forests. Genet Epidemiol 28: 171-182.
34. Zyriax BC, Wolf C, Schlüter A, Khattak AH, Westenhoefer J, et al. (2012) Association of cognitive dietary restraint and disinhibition with prediabetes-cross-sectional and longitudinal data of a feasibility study in German employees. Public Health Nutr 15: 860-867.
35. Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa P, (1999) Waist and hip circumferences, and waisthip ratio in 19 populations of the WHO MONICA Project. Int J Obes Relat Metab Disord 23: 116-125.
36. Bohlscheid TS, Hoting I, Boeing H, Wahrendorf J, (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German Part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26: S59-S70.
37. Bohlscheid TS, Hoting I, Boeing H, (1997) Wahrendorf (1997) Reproducibility and relative validity of energy and macronutrient intake of a food frequency questionnaire developed for the German Part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26: S71-S81.
38. Boeing H, Wahrendorf J, Becker N, (1993) EPIC-Germany- a source for studies into diet and risk of chronic diseases. Ann Nutr Metab 43: 195-204.
39. Schöttker B, Herder C, Rothenbacher D, Roden M, Kolb H, et al. (2013) Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetes Patients With or Without Renal Dysfunction: Results from the ESTHER study. Diabetes Care 36: 1703-1711.
40. Schulze MB, Kroke A, Saracci R, Boeing H, (2002) The effect of differences in measurement procedure on the comparability of blood pressure estimates in multi-centre studies. Blood Press Monit 7: 95-104.
41. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
42. Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, et al. (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25: 1371-1377.
43. Alberti KG, Zimmet P, Shaw J, (2005) IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
44. Oeth P, del Mistro G, Marnellos G, Shi T, van den Boom D, (2009) Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY). Methods Mol Biol 578: 307-343.
45. R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, Available: http://www.R-project.org/. Accessed 27 August 2013.
46. Hothorn T, Buehlmann P, Dudoit S, Molinaro A, Van Der Laan M, (2006) Survival Ensembles. Biostatistics 7: 355-373.
47. Strobl C, Boulesteix AL, Zeileis A, Hothorn T (2007) Bias in Random Forest Variable Importance Measures: Illustrations, Sources and a Solution. BMC Bioinformatics, 8(25). Available: http://www.biomedcentral.com/1471-2105/8/25. Accessed 27 August 2013.
48. Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A (2008) Conditional Variable Importance for Random Forests. BMC Bioinformatics, 9(307). Available: http://www.biomedcentral.com/1471-2105/9/307. Accessed 27 August 2013.
49. Strobl C, Malley J, Tutz G, (2009) An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 14: 323-348.
50. Ding EL, Song Y, Malik VS, Liu S, (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295: 1288-1299.
51. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO, (2006) Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 95: 136-147.
52. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L, (2009) Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 32: 281-286.
53. Abdul-Ghani MA, Stern MP, Lyssenko V, Tuomi T, Groop L, et al. (2010) Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose. Diabetes Care 33: 557-561.
54. Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, et al. (2007) Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clin Chem Lab Med 45: 1180-1185.
55. Rathmann W, Strassburger K, Heier M, Holle R, Thorand B, (2209) Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 26: 1212-1219.
56. Shaw J, Zimmet P, de Courten M, Dowse G, Chitson P, (1999) Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care 22: 399-402.
57. Janghorbani M, Amini M, (2009) Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: the Isfahan diabetes prevention study. Rev Diabet Stud 6: 117-123.
58. Unwin N, Shaw J, Zimmet P, Alberti KGMM, (2002) Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 19: 708-723.
59. Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, et al. (2007) High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care. 30: 332-336.
60. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
61. Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, et al. (2007) Adipokines and risk of type 2 diabetes in older men. Diabetes Care 30: 1200-1205.
62. Raynor LA, Pankow JS, Duncan BB, Schmidt MI, Hoogeveen RC, et al. (2013) Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 36: 70-76.
63. Marques-Vidal P, Schmid R, Bochud M, Bastardot F, von Känel R, et al. (2012) Adipocytokines, Hepatic and Inflammatory Biomarkers and Incidence of Type 2 Diabetes. The CoLaus Study. PLoS One 7: e51768. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0051768. Accessed 27 August 2013.
64. Qi L, Liang J, (2010) Interactions between genetic factors that predict diabetes and dietary factors that ultimately impact on risk of diabetes. Curr Opin Lipidol 21: 31-37.
65. Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, et al. (2009) Evidence of interaction between type 2 diabetes susceptibility genes and dietary fat intake for adiposity and glucose homeostasis-related phenotypes. J Nutrigenet Nutrigenomics 2: 225-234.
66. Ruchat SM, Weisnagel JS, Rankinen T, Bouchard C, Vohl MC, et al. (2009) Interaction between HNF4A polymorphisms and physical activity in relation to type 2 diabetes-related traits: results from the Quebec Family Study. Diabetes Res Clin Pract 84: 211-218.
67. Small KS, Hedman AK, Grundberg E, Nica AC, Thorleifsson G, et al. (2011) Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet 43: 561-564.
68. Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G et al. (2009) Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 5: e1000730. Available: http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1000730. Accessed 27 August 2013.
69. Ohshige T, Iwata M, Omori S, Tanaka Y, Hirose H et al. (2011) Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese. PLoS One 6: e26911. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0026911. Accessed 27 June 2013.
70. Chen G, Bentley A, Adeyemo A, Shriner D, Zhou J, et al. (2012) Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans. Hum Mol Genet 21: 4530-4536.
71. Zhang J, Bakheet R, Parhar RS, Huang CH, Hussain MM, et al. (2011) Regulation of fat storage and reproduction by Krüppel-like transcription factor KLF3 and fat-associated genes in Caenorhabditis elegans. J Mol Biol 411: 537-553.
72. Ng MC, Saxena R, Li J, Palmer ND, Dimitrov L, et al. (2013) Transferability and Fine Mapping of Type 2 Diabetes Loci in African Americans: The Candidate Gene Association Resource Plus Study. Diabetes 62: 965-976.
73. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 41: 909-914.
74. Vimaleswaran KS, Loos RJ (2010) Progress in the genetics of common obesity and type 2 diabetes. Expert Rev Mol Med 12: e7. Available: http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=7293768. Accessed 27 August 2013.
75. Liu Y, Liu Z, Song Y, Zhou D, Zhang D, et al. (2010) Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity (Silver Spring) 18: 1619-1624.
76. Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H (2012) A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population. PLoS One 7: e46263. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0046263. Accessed 27 August 2013.
77. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, et al. (2011) Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60: 2624-2634.
78. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
79. Rees SD, Hydrie MZ, Shera AS, Kumar S, O'Hare JP, et al. (2011) Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia 54: 1368-1374.